Sanofi-GSK delay Covid-19 vaccine to late 2021 in setback to global fight

Topics Coronavirus Vaccine | Sanofi  | GSK

Sanofi and GlaxoSmithKline said clinical trials of their COVID-19 vaccine showed an insufficient immune response in older people, delaying its launch to late next year and marking a setback in the global fight against the pandemic. The announcement on Friday, which highlighted the challenges of developing shots at record speed, hinders efforts to develop the multiple options that experts say the world needs to counter a disease that has killed over 1.

5 million people. The news, which came on the same day as Australia axed a domestic.

This article is no longer available in our repository.

There could be multiple reasons for this.